Literature DB >> 1297314

Tetrahydrobiopterin-dependent formation of endothelium-derived relaxing factor (nitric oxide) in aortic endothelial cells.

K Schmidt1, E R Werner, B Mayer, H Wachter, W R Kukovetz.   

Abstract

Inhibition of tetrahydrobiopterin (H4biopterin) biosynthesis in endothelial cells almost completely abolished the agonist-induced formation of endothelium-derived relaxing factor (EDRF) (NO). This inhibitory effect could be antagonized when H4biopterin biosynthesis was restored by activating a salvage pathway. These data indicate that the formation of EDRF strictly depends on the presence of intracellular H4biopterin, which, in addition to Ca2+, may represent a further physiological and/or pathophysiological regulatory of endothelial NO synthases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1297314      PMCID: PMC1130682          DOI: 10.1042/bj2810297

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Kinetic characteristics of nitric oxide synthase from rat brain.

Authors:  R G Knowles; M Palacios; R M Palmer; S Moncada
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

Review 2.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

3.  Establishment of a human cell line highly expressing endothelin in serum-free medium.

Authors:  M Kondo; N Ishida; M Kobayashi; Y Mitsui
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

Review 4.  Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin.

Authors:  C A Nichol; G K Smith; D S Duch
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

5.  Analysis of reduced forms of biopterin in biological tissues and fluids.

Authors:  T Fukushima; J C Nixon
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

6.  Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages.

Authors:  N S Kwon; C F Nathan; D J Stuehr
Journal:  J Biol Chem       Date:  1989-12-05       Impact factor: 5.157

7.  Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells.

Authors:  U Förstermann; J S Pollock; H H Schmidt; M Heller; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

8.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate.

Authors:  M A Marletta; P S Yoon; R Iyengar; C D Leaf; J S Wishnok
Journal:  Biochemistry       Date:  1988-11-29       Impact factor: 3.162

9.  Serum aluminum levels and erythrocyte dihydropteridine reductase activity in patients on hemodialysis.

Authors:  P Altmann; F Al-Salihi; K Butter; P Cutler; J Blair; R Leeming; J Cunningham; F Marsh
Journal:  N Engl J Med       Date:  1987-07-09       Impact factor: 91.245

10.  Biopterin. III. Purification and characterization of enzymes involved in the cerebral synthesis of 7,8-dihydrobiopterin.

Authors:  E M Gál; J M Nelson; A D Sherman
Journal:  Neurochem Res       Date:  1978-02       Impact factor: 3.996

View more
  24 in total

1.  The effect of insufficiency of tetrahydrobiopterin on endothelial function and vasoactivity.

Authors:  Satoshi Yamashiro; Yukio Kuniyoshi; Katsuya Arakaki; Kazufumi Miyagi; Kageharu Koja
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-11

2.  Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity.

Authors:  P Rosenkranz-Weiss; W C Sessa; S Milstien; S Kaufman; C A Watson; J S Pober
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 3.  Nitric oxide synthases in mammals.

Authors:  R G Knowles; S Moncada
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

4.  Beneficial effects of polyphenol-rich olive oil in patients with early atherosclerosis.

Authors:  R J Widmer; M A Freund; A J Flammer; J Sexton; R Lennon; A Romani; N Mulinacci; F F Vinceri; L O Lerman; A Lerman
Journal:  Eur J Nutr       Date:  2012-08-08       Impact factor: 5.614

5.  Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

Authors:  E Stroes; J Kastelein; F Cosentino; W Erkelens; R Wever; H Koomans; T Lüscher; T Rabelink
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

6.  Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia.

Authors:  Y Fukuda; H Teragawa; K Matsuda; T Yamagata; H Matsuura; K Chayama
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

7.  Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk.

Authors:  Lian Zhang; Fangwen Rao; Kuixing Zhang; Srikrishna Khandrika; Madhusudan Das; Sucheta M Vaingankar; Xuping Bao; Brinda K Rana; Douglas W Smith; Jennifer Wessel; Rany M Salem; Juan L Rodriguez-Flores; Sushil K Mahata; Nicholas J Schork; Michael G Ziegler; Daniel T O'Connor
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 8.  In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide.

Authors:  B Mayer; E R Werner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

Review 9.  Tetrahydrobiopterin, superoxide, and vascular dysfunction.

Authors:  Jeannette Vásquez-Vivar
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

10.  Increases in endothelial cyclic AMP levels amplify agonist-induced formation of endothelium-derived relaxing factor (EDRF).

Authors:  W F Graier; K Groschner; K Schmidt; W R Kukovetz
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.